Pravastatin, A 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Renal Injury in an Experimental Model of Ischemia-Reperfusion
Authors:
- Myles JoyceMJMyles Joyce
- Cathal KellyCKCathal Kelly
- Des WinterDWDes Winter
- Gang ChenGCGang Chen
- Austin LeahyALAustin Leahy
- David Bouchier-HayesDBDavid Bouchier-Hayes
- 1 November 2001
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 101 (1) , 79-84
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm TrialBritish Journal of Surgery, 2000
- The Impact of Ischemia/Reperfusion Injury on Specific and Non-Specific, Early and Late Chronic Events After Organ TransplantationTransplantation Reviews, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Reduction in Cardiovascular Events During Pravastatin TherapyCirculation, 1995
- DELAYED GRAFT FUNCTION, ACUTE REJECTION, AND OUTCOME AFTER CADAVER RENAL TRANSPLANTATIONTransplantation, 1995
- Mechanisms of ischemic acute renal failureKidney International, 1993
- Renal Failure after Operation for Abdominal Aortic AneurysmAnnals of Vascular Surgery, 1990
- Regulation of the mevalonate pathwayNature, 1990
- EARLY FUNCTION AS THE PRINCIPAL CORRELATE OF GRAFT SURVIVALTransplantation, 1988
- Inhibition of Cholesterol Synthesis in vitro and in vivo by ML‐236A and ML‐236B, Competitive Inhibitors of 3‐Hydroxy‐3‐methylglutaryl‐Coenzyme A ReductaseEuropean Journal of Biochemistry, 1977